Agios Pharmaceuticals | AGIO - Ordinary Share Capital

Stock Price
29.25
Daily Change
0.67 2.34%
Monthly
7.66%
Yearly
-16.95%
Q1 Forecast
28.34

Agios Pharmaceuticals reported $58.45M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amgen USD 539M 1000K Dec/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Astellas Pharma JPY 1.79B 195K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bayer EUR 982.42M 0 Sep/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Exelixis USD 268.1M 2.03M Sep/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Moderna USD 391M 2M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Novartis USD 1.94B 23.4M Jun/2025
Novartis USD 1.92B 17.06M Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025